Monocyte-induced recovery of inflammation-associated hepatocellular dysfunction in a biochip-based human liver model

Liver dysfunction is an early event in sepsis-related multi-organ failure. We here report the establishment and characterization of a microfluidically supported in vitro organoid model of the human liver sinusoid. The liver organoid is composed of vascular and hepatocyte cell layers integrating non-parenchymal cells closely reflecting tissue architecture and enables physiological cross-communication in a bio-inspired fashion. Inflammation-associated liver dysfunction was mimicked by stimulation with various agonists of toll-like receptors. TLR-stimulation induced the release of pro- and anti-inflammatory cytokines and diminished expression of endothelial VE-cadherin, hepatic MRP-2 transporter and apolipoprotein B (ApoB), resulting in an inflammation-related endothelial barrier disruption and hepatocellular dysfunction in the liver organoid. However, interaction of the liver organoid with human monocytes attenuated inflammation-related cell responses and restored MRP-2 transporter activity, ApoB expression and albumin/urea production. The cellular events observed in the liver organoid closely resembled pathophysiological responses in the well-established sepsis model of peritoneal contamination and infection (PCI) in mice and clinical observations in human sepsis. We therefore conclude that this human liver organoid model is a valuable tool to investigate sepsis-related liver dysfunction and subsequent immune cell-related tissue repair/remodeling processes.

[1]  K. Brouwer,et al.  Pharmacokinetics of 5 (and 6)-Carboxy-2′,7′-Dichlorofluorescein and Its Diacetate Promoiety in the Liver , 2003, Journal of Pharmacology and Experimental Therapeutics.

[2]  P. Allavena,et al.  Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. , 2002, Trends in immunology.

[3]  Z. Kmieć,et al.  Introduction — Morphology of the Liver Lobule , 2001 .

[4]  Teck Chuan Lim,et al.  A microfluidic 3D hepatocyte chip for drug toxicity testing. , 2009, Lab on a chip.

[5]  Michael Bauer,et al.  In vivo imaging of hepatic excretory function in the rat by fluorescence microscopy , 2012, Journal of biophotonics.

[6]  C. Geis,et al.  Impact of Antibiotic Treatment Intensity on Long-Term Sepsis-Associated Kidney Injury in a Polymicrobial Peritoneal Contamination and Infection Model , 2015, Nephron.

[7]  C. Gandhi,et al.  The Transcriptomic Response of Rat Hepatic Stellate Cells to Endotoxin: Implications for Hepatic Inflammation and Immune Regulation , 2013, PloS one.

[8]  S. Lorkowski,et al.  Microfluidically supported biochip design for culture of endothelial cell layers with improved perfusion conditions , 2015, Biofabrication.

[9]  André Guillouzo,et al.  Evolving Concepts in Liver Tissue Modeling and Implications for in Vitro Toxicology 1. Introduction , 2022 .

[10]  Rachel J. Johnson,et al.  Hepatic Mrp4 induction following acetaminophen exposure is dependent on Kupffer cell function. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[11]  Elizabeth R. Duffy,et al.  Sepsis Chronically in MARS: Systemic Cytokine Responses Are Always Mixed Regardless of the Outcome, Magnitude, or Phase of Sepsis , 2012, The Journal of Immunology.

[12]  T. Billiar,et al.  Liver nonparenchymal cells are stimulated to provide interleukin 6 for induction of the hepatic acute-phase response in endotoxemia but not in remote localized inflammation. , 1992, Archives of surgery.

[13]  Edward T. Morgan,et al.  Gene-Specific Effects of Inflammatory Cytokines on Cytochrome P450 2C, 2B6 and 3A4 mRNA Levels in Human Hepatocytes , 2007, Drug Metabolism and Disposition.

[14]  J. Kelm,et al.  Multi-cell type human liver microtissues for hepatotoxicity testing , 2012, Archives of Toxicology.

[15]  Melvin E. Andersen,et al.  Organotypic liver culture models: Meeting current challenges in toxicity testing , 2012, Critical reviews in toxicology.

[16]  Michael Bauer,et al.  The liver in sepsis: patterns of response and injury , 2013, Current opinion in critical care.

[17]  W. Stremmel,et al.  The Hepatic Microvascular Responses to Sepsis , 2000, Seminars in thrombosis and hemostasis.

[18]  Christian Trepo,et al.  Infection of a human hepatoma cell line by hepatitis B virus , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[19]  E. Rossmanith,et al.  Monocytes, Peripheral Blood Mononuclear Cells, and THP-1 Cells Exhibit Different Cytokine Expression Patterns following Stimulation with Lipopolysaccharide , 2013, Mediators of inflammation.

[20]  Adam S. Hayward,et al.  Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME , 2013, Archives of Toxicology.

[21]  Z. Prohászka,et al.  Proinflammatory activation pattern of human umbilical vein endothelial cells induced by IL‐1β, TNF‐α, and LPS , 2010, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[22]  E. Jaffe,et al.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. , 1973, The Journal of clinical investigation.

[23]  D. Häussinger,et al.  Hepatic and pancreatic stellate cells in focus , 2009, Biological chemistry.

[24]  F. Sonntag,et al.  A dynamic multi-organ-chip for long-term cultivation and substance testing proven by 3D human liver and skin tissue co-culture. , 2013, Lab on a chip.

[25]  W. Humphreys,et al.  CYP3A4 induction by xenobiotics: biochemistry, experimental methods and impact on drug discovery and development. , 2004, Current drug metabolism.

[26]  M. Bauer,et al.  Hepatic Fibrosis in a Long-term Murine Model of Sepsis , 2012, Shock.

[27]  J. Rodríguez-Miguélez,et al.  Serum soluble ICAM-1, VCAM-1, L-selectin, and P-selectin levels as markers of infection and their relation to clinical severity in neonatal sepsis. , 2007, American journal of perinatology.

[28]  J. Privratsky,et al.  PECAM-1: conflicts of interest in inflammation. , 2010, Life sciences.

[29]  T. Wynn,et al.  Protective and pathogenic functions of macrophage subsets , 2011, Nature Reviews Immunology.

[30]  R. Hotchkiss,et al.  Immunotherapy for sepsis--a new approach against an ancient foe. , 2010, The New England journal of medicine.

[31]  W. Peitsch,et al.  Unique Cell Type-Specific Junctional Complexes in Vascular Endothelium of Human and Rat Liver Sinusoids , 2012, PloS one.

[32]  Jürgen Popp,et al.  Liver Dysfunction and Phosphatidylinositol-3-Kinase Signalling in Early Sepsis: Experimental Studies in Rodent Models of Peritonitis , 2012, PLoS medicine.

[33]  B. Drénou,et al.  Transdifferentiation of hepatocyte‐like cells from the human hepatoma HepaRG cell line through bipotent progenitor , 2007, Hepatology.

[34]  Keizo Takao,et al.  Genomic responses in mouse models greatly mimic human inflammatory diseases , 2014, Proceedings of the National Academy of Sciences.

[35]  T. V. van Berkel,et al.  New Scavenger Receptor-Like Receptors for the Binding of Lipopolysaccharide to Liver Endothelial and Kupffer Cells , 1998, Infection and Immunity.

[36]  E. Tønnesen,et al.  Soluble Adhesion Molecules Correlate with Surface Expression in an In Vitro Model of Endothelial Activation , 2013, Basic & clinical pharmacology & toxicology.

[37]  S. V. van Deventer,et al.  Lipid composition and lipopolysaccharide binding capacity of lipoproteins in plasma and lymph of patients with systemic inflammatory response syndrome and multiple organ failure. , 2003, Critical care medicine.

[38]  Frank Tacke,et al.  Macrophage heterogeneity in liver injury and fibrosis. , 2014, Journal of hepatology.

[39]  R. Hotchkiss,et al.  Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy , 2013, Nature Reviews Immunology.

[40]  C. Denis.  Molecular and Cellular Biology of von Willebrand Factor , 2002, International journal of hematology.

[41]  B. Gewertz,et al.  Interleukin-6 causes endothelial barrier dysfunction via the protein kinase C pathway. , 2002, The Journal of surgical research.

[42]  Michael Bauer,et al.  A microfluidically perfused three dimensional human liver model. , 2015, Biomaterials.

[43]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[44]  L. Rubin,et al.  A cell culture model of the blood-brain barrier , 1991, The Journal of cell biology.

[45]  F. Tacke,et al.  Cellular and molecular functions of hepatic stellate cells in inflammatory responses and liver immunology. , 2014, Hepatobiliary surgery and nutrition.

[46]  Michael L Shuler,et al.  Multi-cellular 3D human primary liver cell culture elevates metabolic activity under fluidic flow. , 2015, Lab on a chip.

[47]  K. Wake.  Hepatic stellate cells: Three-dimensional structure, localization, heterogeneity and development , 2006, Proceedings of the Japan Academy. Series B, Physical and biological sciences.

[48]  Z. Kmieć,et al.  Cooperation of Liver Cells in Health and Disease , 2001, Advances in Anatomy Embryology and Cell Biology.

[49]  Henry E. Wang,et al.  Inflammatory and endothelial activation biomarkers and risk of sepsis: a nested case-control study. , 2013, Journal of critical care.

[50]  Luc Bouwens,et al.  Quantitation, tissue distribution and proliferation kinetics of kupffer cells in normal rat liver , 1986, Hepatology.

[51]  M. Trauner,et al.  Mechanisms of Disease: mechanisms and clinical implications of cholestasis in sepsis , 2006, Nature Clinical Practice Gastroenterology &Hepatology.

[52]  D. Müller,et al.  Ethylmorphine-N-demethylation by liver homogenate of newborn and adult rats; Enzyme kinetics and age course of Vmax and Km1. , 1977, Acta biologica et medica Germanica.

[53]  A. Lekkou,et al.  Serum lipid profile, cytokine production, and clinical outcome in patients with severe sepsis. , 2014, Journal of critical care.

[54]  Manjunath Hegde,et al.  Long-term maintenance of a microfluidic 3D human liver sinusoid. , 2016, Biotechnology and bioengineering.

[55]  W. Aird.  The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. , 2003, Blood.

[56]  C. Lawson,et al.  ICAM-1 signaling in endothelial cells , 2009, Pharmacological reports : PR.

[57]  R. Schwabe,et al.  TLR4 enhances TGF-beta signaling and hepatic fibrosis. , 2007, Nature medicine.

[58]  Henry Yang,et al.  Human monocytes undergo functional re-programming during sepsis mediated by hypoxia-inducible factor-1α. , 2015, Immunity.

[59]  K. Ohshima,et al.  Phenotype for activated tissue macrophages in histiocytic necrotizing lymphadenitis , 2009, Pathology international.

[60]  Michael P Holt,et al.  Identification and characterization of infiltrating macrophages in acetaminophen‐induced liver injury , 2008, Journal of leukocyte biology.

[61]  R. Gamelli,et al.  Genomic responses in mouse models poorly mimic human inflammatory diseases , 2013, Proceedings of the National Academy of Sciences.

[62]  M. Bauer,et al.  Characteristics of clinical sepsis reflected in a reliable and reproducible rodent sepsis model. , 2011, The Journal of surgical research.

[63]  H. Fujino,et al.  Different expression patterns of hepatic cytochrome P450 s during anaphylactic or lipopolysaccharide-induced inflammation. , 2014, Die Pharmazie.

[64]  A. Guillouzo,et al.  Catecholamines induce an inflammatory response in human hepatocytes , 2008, Critical care medicine.

[65]  D. Dormont,et al.  Macrophage activation switching: an asset for the resolution of inflammation , 2005, Clinical and experimental immunology.

[66]  Ute Hofmann,et al.  A Systematic Comparison of the Impact of Inflammatory Signaling on Absorption, Distribution, Metabolism, and Excretion Gene Expression and Activity in Primary Human Hepatocytes and HepaRG Cells , 2015, Drug Metabolism and Disposition.